(Q38478125)

3 September 2017

title

A phase II study of CHIP in advanced squamous cell carcinoma of the cervix (a Gynecologic Oncology Group Study). (English)

1 reference

cervical squamous cell carcinoma

3 September 2017

main subject

1 reference

1 reference

W P McGuire

1

1 reference

3 September 2017

J A Blessing

series ordinal

2

1 reference

3 September 2017

K Hatch

series ordinal

3

1 reference

3 September 2017

P J DiSaia

series ordinal

4

1 reference

3 September 2017

publication date

1 January 1986

1 reference

Investigational New Drugs

3 September 2017

published in

1 reference

3 September 2017

volume

4

1 reference

3 September 2017

issue

2

1 reference

3 September 2017

page(s)

181-186

1 reference

Phase I clinical trial of cis-dichloro-trans-dihydroxy-bis-isopropylamine platinum(IV) (CHIP).

3 September 2017

cites work

1 reference

https://pubmed.ncbi.nlm.nih.gov/3733378

PubMed

reference URL

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Blood clearance of three radioactively labelled platinum complexes: cis-dichlorodiammine platinum II, cis, trans-dichlorodihydroxy-bis-(isopropylamine) platinum IV, and cis-dichloro-bis-cyclopropylamine platinum II, in patients with malignant diseas

1 reference

https://pubmed.ncbi.nlm.nih.gov/3733378

PubMed

reference URL

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Cis-platinum in treatment of advanced or recurrent squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/3733378

PubMed

reference URL

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/BF00194600

1 reference

Dimensions Publication ID

3 September 2017

1008737429

0 references

1 reference